Theratechnologies Files 6-K Report
| Field | Detail |
|---|---|
| Company | Theratechnologies Inc. |
| Form Type | 6-K |
| Filed Date | Sep 12, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: filing, 6-K, press-release
TL;DR
Theratechnologies filed a 6-K, check the press release for updates.
AI Summary
Theratechnologies Inc. filed a Form 6-K on September 12, 2025, reporting information for the month of September 2025. The filing includes a press release dated September 12, 2025, as Exhibit 99.1. The company is incorporated in Canada and its principal executive office is located in Montreal, Quebec.
Why It Matters
This filing provides an update on Theratechnologies Inc.'s activities and may contain material information relevant to investors.
Risk Assessment
Risk Level: low — This is a routine filing (6-K) that typically contains press releases or other periodic information, not usually indicative of immediate high risk.
Key Players & Entities
- Theratechnologies Inc. (company) — Registrant
- September 12, 2025 (date) — Filing Date and Press Release Date
- Jocelyn Lafond (person) — General Counsel and Corporate Secretary
- Montreal, Quebec (location) — Principal Executive Office
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is filed by foreign private issuers to report information that they have made or are required to make public pursuant to the laws of their home country, or that they have filed or are required to file with a stock exchange on which their securities are traded.
What specific exhibit is included in this 6-K filing?
Exhibit 99.1, a Press Release Dated September 12, 2025, is included in this filing.
Where is Theratechnologies Inc. headquartered?
Theratechnologies Inc.'s principal executive office is located at 2015 Peel Street, Suite 1100, Montreal, Quebec, Canada.
What is the SEC file number for Theratechnologies Inc.?
The SEC file number for Theratechnologies Inc. is 001-35203.
Does Theratechnologies Inc. file annual reports under Form 20-F or 40-F?
The filing indicates that Theratechnologies Inc. files annual reports under cover of Form 20-F.
Filing Stats: 151 words · 1 min read · ~1 pages · Grade level 11.1 · Accepted 2025-09-12 14:07:03
Filing Documents
- d83861d6k.htm (6-K) — 9KB
- d83861dex991.htm (EX-99.1) — 12KB
- g83861g0912212441201.jpg (GRAPHIC) — 3KB
- 0001193125-25-202066.txt ( ) — 27KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. THERATECHNOLOGIES INC. By: /s/ Jocelyn Lafond Name: Jocelyn Lafond Title: General Counsel and Corporate Secretary Date: September 12, 2025